Home / FEM1C Knockout Cell Lines

FEM1C Knockout Cell Lines

Gene: FEM1C

Official Full Name: fem-1 homolog Cprovided by HGNC

Gene Summary: Enables ubiquitin-like ligase-substrate adaptor activity. Involved in ubiquitin-dependent protein catabolic process via the C-end degron rule pathway. Located in cytosol and nucleoplasm. Part of Cul2-RING ubiquitin ligase complex. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO17633 FEM1C Knockout cell line (HeLa) Human FEM1C 1:3~1:6 Negative Online Inquiry
KO17634 FEM1C Knockout cell line (HCT 116) Human FEM1C 1:2~1:4 Negative Online Inquiry
KO17635 FEM1C Knockout cell line (HEK293) Human FEM1C 1:3~1:6 Negative Online Inquiry
KO17636 FEM1C Knockout cell line (A549) Human FEM1C 1:3~1:4 Negative Online Inquiry

Background

FEM1C Gene Knockout Cell Lines are meticulously engineered biological tools designed to elucidate the functional roles of the FEM1C gene, a critical component in various cellular processes including apoptosis and cell cycle regulation. These cell lines have undergone precise gene editing techniques to create knockout variants that lack functional FEM1C, allowing for in-depth investigations into its biological significance and contributions to significant signaling pathways.

The key function of these knockout cell lines lies in their ability to facilitate functional genomic studies. By providing a model system where the FEM1C gene is absent, researchers can analyze the downstream effects on cellular behavior, signal transduction mechanisms, and gene expression profiles. This stark contrast to wild-type cell lines enables clearer interpretations of the gene’s roles in pathology and normal cellular physiology.

The scientific importance of FEM1C Gene Knockout Cell Lines cannot be overstated. They are indispensable in both basic and applied research, particularly in studies related to cancer biology, developmental biology, and therapeutic strategies. In clinical settings, these models can aid in identifying the contributions of FEM1C to disease states, potentially guiding novel therapeutic interventions targeting related pathways.

What sets FEM1C Gene Knockout Cell Lines apart from alternative models is their unparalleled specificity and reliability, achieved through advanced CRISPR/Cas9 techniques that ensure precise gene disruption without off-target effects. Furthermore, these cell lines come with robust characterization data, providing confidence in reproducibility and enabling researchers to focus on their experimental designs rather than preliminary validations.

For researchers and clinicians, leveraging FEM1C Gene Knockout Cell Lines means gaining access to invaluable insights that can accelerate innovation in therapeutic developments. The value of these knockout cell lines is not just in their utility but in the potential breakthroughs they can facilitate in understanding complex biological systems.

Our company is dedicated to advancing scientific discoveries by offering high-quality biological products backed by extensive research and expert support. With a commitment to excellence and innovation, we empower researchers and clinicians to push the boundaries of their studies.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.